These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8576296)

  • 1. Comparison of the kinetics of glyburide and its active metabolites in humans.
    Rydberg T; Jönsson A; Melander A
    J Clin Pharm Ther; 1995 Oct; 20(5):283-95. PubMed ID: 8576296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of glibenclamide and its metabolites in diabetic patients with impaired renal function.
    Jönsson A; Rydberg T; Sterner G; Melander A
    Eur J Clin Pharmacol; 1998 Feb; 53(6):429-35. PubMed ID: 9551701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration-effect relations of glibenclamide and its active metabolites in man: modelling of pharmacokinetics and pharmacodynamics.
    Rydberg T; Jönsson A; Karlsson MO; Melander A
    Br J Clin Pharmacol; 1997 Apr; 43(4):373-81. PubMed ID: 9146849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoglycemic activity of glyburide (glibenclamide) metabolites in humans.
    Rydberg T; Jönsson A; Røder M; Melander A
    Diabetes Care; 1994 Sep; 17(9):1026-30. PubMed ID: 7988301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [14C]tofogliflozin after oral administration and concomitant intravenous microdose administration of [13C]tofogliflozin in humans.
    Schwab D; Portron A; Backholer Z; Lausecker B; Kawashima K
    Clin Pharmacokinet; 2013 Jun; 52(6):463-73. PubMed ID: 23494983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the pharmacokinetics of glibenclamide tablet given, off label, orally to children suffering from neonatal syndromic hyperglycemia.
    Bouazza N; Djerada Z; Gozalo C; Busiah K; Beltrand J; Berdugo M; Urien S; Treluyer JM; Polak M
    Eur J Clin Pharmacol; 2016 Nov; 72(11):1373-1379. PubMed ID: 27561267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of glibenclamide and its two major metabolites in human serum and urine by column liquid chromatography.
    Rydberg T; Wåhlin-Boll E; Melander A
    J Chromatogr; 1991 Mar; 564(1):223-33. PubMed ID: 1907291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of canagliflozin on the pharmacokinetics of glyburide, metformin, and simvastatin in healthy participants.
    Devineni D; Manitpisitkul P; Murphy J; Skee D; Wajs E; Mamidi RN; Tian H; Vandebosch A; Wang SS; Verhaeghe T; Stieltjes H; Usiskin K
    Clin Pharmacol Drug Dev; 2015; 4(3):226-36. PubMed ID: 27140803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers.
    He YL; Sadler BM; Sabo R; Balez S; Wang Y; Campestrini J; Laurent A; Ligueros-Saylan M; Howard D
    Clin Pharmacokinet; 2007; 46(9):787-802. PubMed ID: 17713976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A validated high-performance liquid chromatographic method for the determination of glibenclamide in human plasma and its application to pharmacokinetic studies.
    Niopas I; Daftsios AC
    J Pharm Biomed Anal; 2002 May; 28(3-4):653-7. PubMed ID: 12008145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the primary mechanism of action of an insulin secretagogue from meal test data in healthy volunteers based on an integrated glucose-insulin model.
    Choy S; Hénin E; van der Walt JS; Kjellsson MC; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2013 Feb; 40(1):1-10. PubMed ID: 23179858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absolute bioavailability of glimepiride (Amaryl) after oral administration.
    Badian M; Korn A; Lehr KH; Malerczyk V; Waldhäusl W
    Drug Metabol Drug Interact; 1994; 11(4):331-9. PubMed ID: 12369756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and relative bioavailability of tablet of micronized glibenclamide in 4 Chinese healthy men.
    Cui HD; Jiang WD; Zhu XX; Guo Y; Karras HO
    Zhongguo Yao Li Xue Bao; 1993 May; 14(3):193-7. PubMed ID: 8237389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioequivalence of two oral formulations of glyburide (glibenclamide).
    Flores-Murrieta FJ; Carrasco-Portugal Mdel C; Reyes-García G; Medina-Santillán R; Herrera JE
    Proc West Pharmacol Soc; 2007; 50():64-6. PubMed ID: 18605232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic disposition of 14C-glyburide in patients with varying renal function.
    Pearson JG; Antal EJ; Raehl CL; Gorsch HK; Craig WA; Albert KS; Welling PG
    Clin Pharmacol Ther; 1986 Mar; 39(3):318-24. PubMed ID: 3081293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactions.
    Greupink R; Schreurs M; Benne MS; Huisman MT; Russel FG
    Eur J Pharm Sci; 2013 Aug; 49(5):819-28. PubMed ID: 23806476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of the insulin-sensitizing agent troglitazone in cats.
    Michels GM; Boudinot FD; Ferguson DC; Hoenig M
    Am J Vet Res; 2000 Jul; 61(7):775-8. PubMed ID: 10895899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative determination of metformin, glyburide and its metabolites in plasma and urine of pregnant patients by LC-MS/MS.
    Zhang X; Wang X; Vernikovskaya DI; Fokina VM; Nanovskaya TN; Hankins GD; Ahmed MS
    Biomed Chromatogr; 2015 Apr; 29(4):560-9. PubMed ID: 25164921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of aspirin and ibuprofen on the pharmacokinetics and pharmacodynamics of glyburide in healthy subjects.
    Kubacka RT; Antal EJ; Juhl RP; Welshman IR
    Ann Pharmacother; 1996 Jan; 30(1):20-6. PubMed ID: 8773160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of bromfenac on the pharmacokinetics and pharmacodynamic responses to glyburide in diabetic subjects.
    Boni JP; Cevallos WH; DeCleene S; Korth-Bradley JM
    Pharmacotherapy; 1997; 17(4):783-90. PubMed ID: 9250558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.